Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2024-09-19
DOI
https://doi.org/10.1186/s12885-024-12936-w
Citations
8
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
2.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol

Michele Reni, Federica Iannelli, Mercedes Rodríguez Garrote, Francesca Foschini et al.
8 citations
BMC Cancer
Pancreatic and Hepatic Oncology Research
2.26
article

Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol

Michele Reni, Federica Iannelli, Mercedes Rodríguez Garrote, Francesca Foschini, Claudia Fuchs, Alfredo Budillon, Maria Serena Roca, Elena Di Gennaro, Giampaolo Tortora, Laura García‐Bermejo, Michele Stanislaw Milella, Christine Kubiak, Lucrezia Silvestro, Alessandra Leone, Marina Macchini, Diana Giannarelli, Antonio Avallone, Francesca Bruzzese, Eugenia Passaro, Eve Hewitt
article en
8 citations

Abstract

No abstract available for this paper.
BMC CancerVol. 24(1)
Università Cattolica del Sacro Cuore (IT), University of Verona (IT), European Organisation for Rare Diseases (FR), Vita-Salute San Raffaele University (IT), Agostino Gemelli University Polyclinic (IT), Beacon Clinical Research (US), Instituto Ramón y Cajal de Investigación Sanitaria (ES), IRCCS Ospedale San Raffaele (IT), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), European Clinical Research Infrastructure Network (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
European Commission, Ministero della Salute, HORIZON EUROPE Framework Programme
Good health and well-being
Openalex Percentile: Top 10%
Pancreatic and Hepatic Oncology Research
2.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.